Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PEAKO LIMITED Director's Dealing 2024

Apr 4, 2024

65567_rns_2024-04-04_7e8f8bac-da29-425a-bde9-75bd817b741f.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change in Director's Interest Notice

Rule 3.19A.2

Appendix 3Y Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01. Amended 01/01/11

Name of entity: PEAKO LIMITED
ABN: 79 131 843 868

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Dr Paul Anthony Kitto
Date of last notice 17 October 2023

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest Direct and Indirect
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant interest.
1. Precambrian SMSF (Director)
2. Paul Anthony Kitto
Date of change 29 March 2024
No. of securities held prior to change 1. 1,120,000 Fully paid ordinary shares
1. 100,000 - 30 Sept 2025 options exerciseable at $0.05 (5 cents)
1. 2,000,000 - 25 May 2025 options exerciseable at $0.05 (5 cents)
2. 1,000,000 - 29 March 2024 options exerciseable at $0.06 (6 cents)
2. 1,000,000 - 21 Nov 2024 options exerciseable at $0.10 (10 cents)
2. 1,000,000 - 21 Nov 2025 options exerciseable at $0.20 (20 cents)
1. 120,000 PKOO listed options with expiry 30 June 2025 and
exercise price of $0.025 (2.5 cents)
1. 280,000 Unlisted options with expiry 30 November 2026 and exercise
price of $0.02 (2 cents)
Class 29 March 2024 options exerciseable at $0.06 (6 cents)
Number acquired -
Number disposed 1,000,000
Note: If consideration is non-cash, provide details and estimated valuation
Value/Consideration
Nil
No. of securities held after change 1. 1,120,000 Fully paid ordinary shares
1. 100,000 - 30 Sept 2025 options exerciseable at $0.05 (5 cents)
1. 2,000,000 - 25 May 2025 options exerciseable at $0.05 (5 cents)
2. 1,000,000 - 21 Nov 2024 options exerciseable at $0.10 (10 cents)
2. 1,000,000 - 21 Nov 2025 options exerciseable at $0.20 (20 cents)
1. 120,000 PKOO listed options with expiry 30 June 2025 and
exercise price of $0.025 (2.5 cents)
1. 280,000 Unlisted options with expiry 30 November 2026 and exercise
price of $0.02 (2 cents)
Nature of change
Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan,
participation in buy-back
Expiry of unlisted options unexercised on 29 March 2024.
  • See chapter 19 for defined terms.

Appendix 3Y Page 1

01/01/2011

Appendix 3Y Change in Director's Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Part 3 –+Clos ed period
Were the interests in the securities or contracts detailed above traded during a
+closed period where prior written clearance was required?
N/A
If so, was prior written clearance provided to allow the trade to proceed during
thisperiod?
If prior written clearance was provided, on what date was this provided?
  • See chapter 19 for defined terms.

Appendix 3Y Page 3

01/01/2011